|
|
"How
You Can Help"
Information on the MGH
Neuroendocrine Clinical Center
and Pituitary Tumor Center
Voice: 617.726.7948
Fax: 617.726.1241
Physicians'
Pituitary
Information Service
Physicians
with questions may contact:
DR Biller or DR Klibanski at
617.726.3965 or 1.888.429.6863
e-mail pituitary.info@partners.org
|
The Neuroendocrine
Clinical Center provides a multidisciplinary approach to patients
with pituitary and hypothalamic disorders. Endocrinologists,
Neurologists, and Neurosurgeons participate in the management
of such patients. The Center is a national referral center for
the evaluation and treatment of pituitary tumors, recurrent
pituitary adenomas, and tumors or disorders of the hypothalamic-pituitary
region. The Center is ideally suited for the referral of patients
with pituitary tumors, including prolactinomas, Cushing's disease,
acromegaly, nonfunctioning pituitary tumors, recurrent pituitary
adenomas, and pituitary and hypothalamic disorders which lead
to adrenal, thyroid, ovarian, or testicular deficiency. Patients
can be referred for the development of a treatment plan in conjunction
with their primary physician, for a second opinion, or for ongoing
management by the Center physicians.
- Endocrinologists in the Center
are experienced in the chronic administration of replacement
hormones and in the use of drugs which block hormone excess
syndromes. They are experienced in the use of investigational
drugs for the treatment of prolactin and growth hormone disorders.
They have been at the forefront of medical therapy for pituitary
disorders with the use of new dopamine agonists for prolactinomas
and somatostatin analogues for acromegaly.
- Neurosurgical involvement in
the Center ensures prompt surgical intervention when necessary.
- Input from the Department of
Radiation Medicine facilitates the planning of therapy.
- Neurologists are available for
the pharmacological treatment of headaches, seizures, and
hypothalamic syndromes.
- The Neuroendocrine Clinical
Nurse offers patient education, including teaching self-administration
of medications requiring injection.
|
*
Neuroendocrine Clinical Center - New Location *
The
Neuroendocrine Clinical Center has recently moved to a
new location within Massachusetts General Hospital. The
new location is Zero Emerson Place, Suite 112. To schedule
an appointment, please call 617-726-7948.
|
Scheduling
and Referrals: The Massachusetts
General Hospital Neuroendocrine Clinical Center is located on
the lst floor (Suite 112) of Zero Emerson Place, Boston, Massachusetts,
(off Blossom Street) and directly across from the Massachusetts
General Hospital Gray Lobby. (Select
here for maps of MGH). Outpatient clinical visits and inpatient
consultations can be arranged by calling the Neuroendocrine
Clinical Center Office at (617) 726-7948. Physicians with questions
may contact Dr. Biller or Dr. Klibanski at (617) 726-3965.
Special Instructions (If available,
please bring):
- Copies of your medical records/discharge
summary/physician notes
- a copy of your X rays
- a copy of your lab reports
- If you are presently under
medications, bring them with you to your appointment
- Reminder: Please bring your
current blue hospital card to your appointment. If you do
not have a card or your card needs to be updated, please
go to one of the registration areas at least 20 minutes
prior to your appointment. Thank you.
Outpatient
Service
Diagnosis
The Neuroendocrine Clinical Center
offers detailed outpatient evaluation of all disorders affecting
the endocrine function of the hypothalamus and pituitary gland,
achieved through comprehensive office visits, complete basal
and dynamic hormone testing, and coordination of radiological
studies and visual field evaluations. Patients are presented
at the weekly Neuroendocrine Clinical Conference which is
attended by endocrinologists, neurosurgeons, neurologists,
and radiation therapy physicians. A diagnostic and therapeutic
plan is formulated for each patient and provided to the referring
physician.
Special
Expertise
Areas in which the Neuroendocrine
Clinical Center provides special multidisciplinary expertise
include:
- Pituitary Tumors
- Prolactinomas; Cushing's
disease; Acromegaly; Non-functioning tumors; Recurrent
pituitary adenomas.
- Prolactin Disorders
- Amenorrhea-Galactorrhea
Syndrome; Drug-induced hyperprolactinemia; Infertility;
Male hypogonadism.
- Cushing's Disease
- Pituitary Cushing's; Ectopic
Cushing's; Adrenal Cushing's; Iatrogenic Cushing's,
Recurrent Cushing's.
- Hypopituitarism
- Hypoadrenalism; Hypothyroidism;
Hypogonadism; Growth hormone deficiency.
- Posterior Pituitary Dysfunction
- Diabetes insipidus; Syndrome
of inappropriate antidiuretic hormone secretion.
- Hormone Dependent Neurologic
Disorders
- Hypothalamic Syndromes
- Suprasellar Tumors; Craniopharyngiomas
Stereotactic
Proton Radiosurgery
An innovative program utilizing
proton beam therapy
and conventional radiation therapy for treatment of pituitary
lesions. Laser-guided MR imaged stereotactic intrasellar tumor
localization can be used for selected patients with untreated
pituitary tumors, incomplete surgical resection, or tumor
recurrence.
Speakers
The Neuroendocrine Clinical Center
offers speakers on a wide variety of topics. Lectures, rounds,
and small symposia can be arranged.
Neuroendocrine
Clinical Conference
A weekly interdisciplinary conference
is held to discuss patients referred to the Neuroendocrine
Clinical Center and to review patient management issues. It
is a multidisciplinary conference, attended by the members
of the Neuroendocrine, Neurology, Neurosurgery, and Radiation
Medicine services. Physicians are welcome to attend and present
cases.
Neuroendocrine
Lecture Series
A bimonthly conference is held
on didactic and research topics related to Neuroendocrinology.
Attendance at this series is open to all interested medical
personnel.
Research
Studies Available
Patients may qualify for research studies
in the Neuroendocrine Clinical Center. We are currently accepting
the following categories of patients for screening to determine
study eligibility. Depending on the study, subjects may receive
free testing, medication and/or stipends. [ see Neuroendocrine
Links for more information ]
|
SUBJECTS
|
STUDIES
|
CONTACT
617-726-3870
|
|
Newly diagnosed
acromegaly patients
|
·
Evaluating preoperative medical treatments
|
Karen
Pulaski-Liebert, R.N.
Dr.
Beverly M.K. Biller
|
|
Patients
with Cushing’s Syndrome
|
·
Evaluating a potential new medical
therapy (Anticipated Start: Winter 2006) |
Karen
Pulaski-Liebert, R.N.
Dr.
Beverly M.K. Biller
|
|
Patients
with history of cured acromegaly with or without hypopituitarism
|
·
Body
composition and cardiovascular evaluation
· GH
replacement study in patients with GH deficiency
|
Dr.
Anne Klibanski
Dr.
Karen K. Miller
|
|
Women with
anorexia nervosa
|
·
New therapies |
Dr.
Karen K. Miller
Dr.
Anne Klibanski
|
|
Adolescent
girls with anorexia nervosa
|
·
Evaluating
bone density and the effects of estrogen replacement
|
Dr.
Anne Klibanski
Dr.
Madhu Misra
|
| Healthy
adolescent girls and boys |
To determine extent of growth
hormone suppression following an oral glucose load
|
Dr.
Anne Klibanski
Dr.
Madhu Misra
|
| Healthy
and overweight adolescent girls, ages 12-18 |
Investigating body weight
in relation to GH and ghrelin secretion in adolescents
|
Dr.
Anne Klibanski
Dr.
Madhu Misra
|
|
Women and
adolescent girls with anorexia nervosa
|
·
Investigating effects of rhGH on bone
metabolism |
Dr.
Anne Klibanski
Dr.
Madhu Misra
Dr.
Rajani Prabhakaran
|
|
Women,
ages 18-45
|
·
Investigating
body weight and GH secretion GH treatment in abdominal obesity
|
Dr.
Andrea Utz
Dr.
Karen K. Miller
|
|
Healthy women,
ages 18-45
|
·
Investigating
body weight in relation to GH and ghrelin secretion in adolescents
|
Dr.
Anne Klibanski
Dr.
Madhu Misra
Dr.
Patrika Tsai
|
|
Healthy
women, ages 18-45
|
·
Investigating the link between cortisol
regulation and bone density
|
Dr.
Elizabeth Lawson
Dr.
Karen K. Miller
Dr.
Anne Klibanski
|
|
Women with
irregular menstrual periods (hypothalamic amenorrhea),
ages 18-45
|
· Investigating
the link between cortisol regulation and bone density
|
Dr.
Elizabeth Lawson
Dr.
Karen K. Miller
Dr.
Anne Klibanski
|
|
HIV positive
women with reduced testosterone levels
|
·
Evaluating effects of testosterone
therapy |
Dr.
Steven Grinspoon
Sara
Dolan Looby, N.P.
|
|
HIV positive
men and women with fat redistribution
|
·
Evaluating
effects of testosterone therapy
|
Dr.
Steven Grinspoon
Sara
Dolan Looby, N.P.
|
|
HIV
positive men and women with fat redistribution
|
·
Novel treatments to redistribute fat
· Novel
lipid lowering therapy |
Dr.
Steven Grinspoon
|
|
HIV positive
men and women
|
·
Use of GHRH, a growth hormone secreta
with fat redistribution gogue, to increase endogenous GH
levels, improve fat distribution and lipid profile
· Among
patients with reduced GH response to standard GH secretion
testing, use of low dose GH as above |
Dr.
Steven Grinspoon
|
Facilities
The Massachusetts General Hospital
Neuroendocrine Clinical Center is located on the lst floor (Suite
112) of Zero Emerson Place, Boston, Massachusetts, (off Blossom
Street) and directly across from the Massachusetts General Hospital
Gray Lobby. (Select
here for maps of MGH). Outpatient clinical visits and inpatient
consultations can be arranged by calling the Neuroendocrine
Clinical Center Office at (617) 726-7948. Physicians with questions
may contact Dr. Biller or Dr. Klibanski at (617) 726-3965.
- Facilities include: Examination
rooms; Conference area; Pituitary Test Center; 3-bed area
for dynamic hormone testing.
- Physician or Nurse is available
for: IV insertion; Administration of testing agents; Patient
monitoring.
- Technician present for: Precisely
timed blood sampling; Hand delivery of samples to the laboratory.
- Available tests include: ACTH
(Cortrosyn) stimulation; Insulin tolerance; CRH stimulation;
TRH stimulation; GnRH stimulation; Oral glucose tolerance;
Growth hormone reserve testing.
- The Pituitary Center can arrange
for complete outpatient or in-patient diagnostic testing
for Cushing's syndrome, including bilateral inferior petrosal
sinus ACTH sampling which is considered the definitive test
for Cushing's disease in patients without tumors visible
on head scans.
Inpatient
Consultation Service
The staff is available for inpatient
consultations related to neuroendocrine disorders. All patients
are followed for diagnostic evaluation or hormone management
as required.
"How
You Can Help"
Donations
to the Neuroendocrine Educational and Training Fund may be
sent to the MGH Development Office, Massachusetts General
Hospital, 100 Charles River Plaza, Suite 600, Boston, MA 02114-2792,
(phone 617-726-2200).
Checks
should be made payable to the Neuroendocrine Educational and
Training Fund at Massachusetts General Hospital, and will
be added to the Neuroendocrine Educational and Training Fund.
You may
also make a gift through the MGH
Giving website (or
online directly via secure web site). When making a gift
on line, indicate the designation as "Other, MGH Neuroendocrine
Educational and Training Fund."
![[Neuroendocrine Clinical Home]](/images/PIThome2.JPG) |
Physicians'
Pituitary Information Service
Physicians
with questions may contact Dr Biller or DR Klibanski
at
617.726.3965 or 1.888.429.6863 or via e-mail pituitary.info@partners.org
Physicians
with questions may contact Dr. Biller or Dr. Klibanski
at 617-726-5002 or 800-353-9460.
|
|